Cargando…
Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation
Neuroinflammation is considered to be one of the potential causes for the development of neurodegenerative diseases, including Alzheimer’s disease. In this study, we evaluated the effect of four newly synthesized pyrrolo[3,4-d]pyridazinone derivatives on the neuron-like PC12 cells under simulated in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177677/ https://www.ncbi.nlm.nih.gov/pubmed/32276316 http://dx.doi.org/10.3390/ijms21072575 |
_version_ | 1783525272056758272 |
---|---|
author | Wakulik, Karolina Wiatrak, Benita Szczukowski, Łukasz Bodetko, Dorota Szandruk-Bender, Marta Dobosz, Agnieszka Świątek, Piotr Gąsiorowski, Kazimierz |
author_facet | Wakulik, Karolina Wiatrak, Benita Szczukowski, Łukasz Bodetko, Dorota Szandruk-Bender, Marta Dobosz, Agnieszka Świątek, Piotr Gąsiorowski, Kazimierz |
author_sort | Wakulik, Karolina |
collection | PubMed |
description | Neuroinflammation is considered to be one of the potential causes for the development of neurodegenerative diseases, including Alzheimer’s disease. In this study, we evaluated the effect of four newly synthesized pyrrolo[3,4-d]pyridazinone derivatives on the neuron-like PC12 cells under simulated inflammation conditions by preincubation with lipopolysaccharide (LPS). Our novel derivatives are selective cyclooxygenase-2 (COX-2) inhibitors and have similar effects to nonsteroidal anti-inflammatory drugs (NSAIDs). We assessed viability (LDH assay), metabolic activity (MTT assay), DNA damage (number of double-strand breaks measured by fast halo assay), and the neuronal features of cells (average neurite length and neurite outgrowth measured spectrofluorimetrically). DCF-DA and Griess assays were also performed, which allowed determining the impact of the tested compounds on the level of oxygen free radicals and nitrites. LPS administration significantly negatively affected the results in all tests performed, and treatment with the tested derivatives in most cases significantly reduced this negative impact. Multiple-criteria decision analysis indicated that overall, the best results were observed for compounds 2a and 2b at a concentration of 10 µM. The new derivatives showed intense activity against free oxygen radicals and nitrites. Reduced reactive oxygen species level also correlated with a decrease in the number of DNA damage. The compounds improved neuronal features, such as neurite length and outgrowth, and they also increased cell viability and mitochondrial activity. Our results suggest that derivatives 2a and 2b may also act additionally on mechanisms other than 3a and 3b. |
format | Online Article Text |
id | pubmed-7177677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71776772020-04-28 Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation Wakulik, Karolina Wiatrak, Benita Szczukowski, Łukasz Bodetko, Dorota Szandruk-Bender, Marta Dobosz, Agnieszka Świątek, Piotr Gąsiorowski, Kazimierz Int J Mol Sci Article Neuroinflammation is considered to be one of the potential causes for the development of neurodegenerative diseases, including Alzheimer’s disease. In this study, we evaluated the effect of four newly synthesized pyrrolo[3,4-d]pyridazinone derivatives on the neuron-like PC12 cells under simulated inflammation conditions by preincubation with lipopolysaccharide (LPS). Our novel derivatives are selective cyclooxygenase-2 (COX-2) inhibitors and have similar effects to nonsteroidal anti-inflammatory drugs (NSAIDs). We assessed viability (LDH assay), metabolic activity (MTT assay), DNA damage (number of double-strand breaks measured by fast halo assay), and the neuronal features of cells (average neurite length and neurite outgrowth measured spectrofluorimetrically). DCF-DA and Griess assays were also performed, which allowed determining the impact of the tested compounds on the level of oxygen free radicals and nitrites. LPS administration significantly negatively affected the results in all tests performed, and treatment with the tested derivatives in most cases significantly reduced this negative impact. Multiple-criteria decision analysis indicated that overall, the best results were observed for compounds 2a and 2b at a concentration of 10 µM. The new derivatives showed intense activity against free oxygen radicals and nitrites. Reduced reactive oxygen species level also correlated with a decrease in the number of DNA damage. The compounds improved neuronal features, such as neurite length and outgrowth, and they also increased cell viability and mitochondrial activity. Our results suggest that derivatives 2a and 2b may also act additionally on mechanisms other than 3a and 3b. MDPI 2020-04-08 /pmc/articles/PMC7177677/ /pubmed/32276316 http://dx.doi.org/10.3390/ijms21072575 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wakulik, Karolina Wiatrak, Benita Szczukowski, Łukasz Bodetko, Dorota Szandruk-Bender, Marta Dobosz, Agnieszka Świątek, Piotr Gąsiorowski, Kazimierz Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title | Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title_full | Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title_fullStr | Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title_full_unstemmed | Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title_short | Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation |
title_sort | effect of novel pyrrolo[3,4-d]pyridazinone derivatives on lipopolysaccharide-induced neuroinflammation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177677/ https://www.ncbi.nlm.nih.gov/pubmed/32276316 http://dx.doi.org/10.3390/ijms21072575 |
work_keys_str_mv | AT wakulikkarolina effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT wiatrakbenita effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT szczukowskiłukasz effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT bodetkodorota effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT szandrukbendermarta effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT doboszagnieszka effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT swiatekpiotr effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation AT gasiorowskikazimierz effectofnovelpyrrolo34dpyridazinonederivativesonlipopolysaccharideinducedneuroinflammation |